Clinical Trials Logo

Uterine Serous Carcinoma clinical trials

View clinical trials related to Uterine Serous Carcinoma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04590248 Completed - Clinical trials for Uterine Serous Carcinoma

A Study of Adavosertib as Treatment for Uterine Serous Carcinoma

ADAGIO
Start date: November 30, 2020
Phase: Phase 2
Study type: Interventional

This Phase 2b study aims to evaluate the efficacy and safety of adavosertib, an inhibitor of the tyrosine kinase WEE1, in subjects with recurrent or persistent uterine serous carcinoma (USC) who have previously received at least 1 prior platinum-based chemotherapy regimen for the management of USC.